Finding Funds and Profits in a Tough Biotech Market

Nothing less than a cure for cancer is in the sights of immune medicine pioneer, Adaptive Biotechnologies. But first the business is aiming for profitability, says CFO Tycho Peterson.

PlayWatch video

Stay Informed

Get the latest insights and news from RBC Capital Markets delivered to your inbox.